Skip to content

Facial palsy: current protocols for the diagnosis, treatment and follow-up of patients in Germany and in Austria

Facial palsy: current protocols for the diagnosis, treatment and follow-up of patients in Germany and in Austria

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00022309
Enrollment
500
Registered
2020-06-29
Start date
2021-06-30
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G51.0

Interventions

Sponsors

MED-EL Elektromedizinische Geräte GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Documented diagnosis of facial palsy • Signed and dated informed consent before the start of any registry-specific procedures for subjects recruited prospectively

Exclusion criteria

Exclusion criteria: • Lack of compliance with any inclusion criteria • Other clinical diseases that might result in alteration of the outcomes of this registry (e.g. neuromuscular diseases) • Parallel participation in a device/drug clinical investigation in the period of data collection, which could confound the results of the registry

Design outcomes

Primary

MeasureTime frame
The following information is collected at the beginning of the inclusion of a subject: • Facial palsy etiology and history • Age • Gender The following information /test results are collected for the entire duration of the registry, whenever they are available: • Demographic • Medical history • Medication history • Facial palsy history • Facial palsy treatment record • Videos (e.g. 3D videos) • Photos (e.g. 3D photos) • Ultrasound • MRI • CT scans • EMD • Sunnybrook • Questionnaires: • FDI • FaCE • GBI

Secondary

MeasureTime frame
The secondary outcome is to evaluate the effects of the chosen treatment by comparing the results of the tests performed at the initial visit, with those of the last follow-up visit within 5 years of treatment. Stratification will be based on the type of treatment method chosen.

Countries

Austria, Germany

Contacts

Public ContactPia Plattner

MED-EL Elektromedizinische Geräte GmbH

pia.plattner@medel.com+43577881681

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026